[131I]MIP-1095

N/A

Report date: 2024/10/10 09:07:50

Base Information

Drug Name[131I]MIP-1095
Drug Alias Name1095[131I]MIP-1095[131I]MIP-1466131I-MIP-1095131-I-MIP-1466 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesProgenics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesProgenics Pharmaceuticals Inc
Inactive CompaniesMolecular Insight Pharmaceuticals Inc
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A